v3.25.1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
 [1]
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2023 [1]   1,695,788    
Beginning balance at Dec. 31, 2023 $ 26,768 $ 2 [1] $ 192,029 $ (165,263)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of common stock in connection with at-the-market offering (net of issuance costs), shares [1]   4,329    
Issuance of common stock in connection with at-the-market offering (net of issuance costs) 253   253  
Stock-based compensation 1,318   1,318  
Issuance of common stock under equity plan awards (in shares) [1]   8,901    
Issuance of common stock under equity plan awards 197   197  
Net loss (7,904)     (7,904)
Ending balance (in shares) at Mar. 31, 2024 [1]   1,709,018    
Ending balance at Mar. 31, 2024 20,632 $ 2 [1] 193,797 (173,167)
Beginning balance (in shares) at Dec. 31, 2024 [1]   3,382,432    
Beginning balance at Dec. 31, 2024 19,126 $ 3 [1] 226,229 (207,106)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of common stock in connection with at-the-market offering (net of issuance costs), shares [1]   133,521    
Issuance of common stock in connection with at-the-market offering (net of issuance costs) 1,444 $ 1 [1] 1,443  
Stock-based compensation 1,389   1,389  
Issuance of common stock under equity plan awards (in shares) [1]   3,649    
Issuance of common stock under equity plan awards 34   34  
Net loss (10,860)     (10,860)
Ending balance (in shares) at Mar. 31, 2025 [1]   3,519,602    
Ending balance at Mar. 31, 2025 $ 11,133 $ 4 [1] $ 229,095 $ (217,966)
[1] Shares issued and outstanding have been adjusted to reflect the one-for-thirteen stock split effected in April 2025. See Note 1, Organization and Description of the Business, for details.